EdgarLookup
SC 13D/A

AMENDMENT NO. 4 TO SCHEDULE 13D

Company
Actinium Pharmaceuticals, Inc.
Filed
July 5, 2016
Accession Number
0000921895-16-005079
View Document ↗ View on SEC.gov ↗